“Romastru is present in drugstores with nine own brands. Most of them are cancer and neurology drugs. Sales of our own brands recorded since the beginning of last year amount to around EUR2 million,” said Cristian Bota, the company’s general manager.
Romastru’s core business is pharmaceutical marketing, which entails providing medical promotional activities for companies either not present on the Romanian market or that have outsourced this activity. The company is also a wholesaler, but has a smaller number of products than the major wholesalers. The company works with 17 suppliers, both domestic and foreign. At the end of 2009 the company launched its own generic drug brands, manufactured by companies in the EU (90%) and India.
“Romastru’s intention is to expand its portfolio of own brands. New brands will be launched over the next few months, with the company’s portfolio expected to include 15 brands by the end of the year,” Bota said. “This is a continuous process of registering areas with potential, analyzing patents, identifying suppliers for generics, registering and launching the products onto the market.” Romastru is set to launch more than 40 products between 2011 and 2013.